Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11535868 Miniaturized dystrophins having spectrin fusion domains and uses thereof

Patent 11535868 was granted and assigned to Bristol-Myers Squibb on December, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

Disclosed herein are nucleic acid molecules, polypeptides, cells, vectors, and pharmaceutical compositions relating to miniaturized dystrophin. Methods of production and methods of therapeutic use of the miniaturized dystrophin are also disclosed.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11535868 Miniaturized dystrophins having spectrin fusion domains and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo